| |
Full sample
|
Paper
|
Web
|
|---|
|
Non-respondents
|
Respondents
| |
Non-respondents
|
Respondents
| |
Non-respondents
|
Respondents
| |
|---|
|
n
|
%
|
n
|
%
|
P
|
n
|
%
|
n
|
%
|
P
|
n
|
%
|
n
|
%
|
P
|
|---|
|
Time since diagnosis
|
0.022
| | | | |
0.144
| | | | |
0.076
|
|
Long-term
|
114
|
59.4
|
78
|
40.6
| |
53
|
55.2
|
43
|
44.8
| |
61
|
63.5
|
35
|
36.5
| |
|
Recent
|
123
|
48.4
|
131
|
51.6
| |
59
|
45.4
|
71
|
54.6
| |
64
|
51.6
|
60
|
48.4
| |
|
Sex
|
0.130
| | | | |
0.016
| | | | |
0.760
|
|
Female
|
126
|
50.0
|
126
|
50.0
| |
55
|
42.6
|
74
|
57.4
| |
71
|
57.7
|
52
|
42.3
| |
|
Male
|
111
|
57.2
|
83
|
42.8
| |
57
|
58.8
|
40
|
41.2
| |
54
|
55.7
|
43
|
44.3
| |
|
Current age
|
0.028
| | | | |
0.223
| | | | |
0.139
|
|
< 40
|
47
|
63.5
|
27
|
36.5
| |
21
|
60.0
|
14
|
40.0
| |
26
|
66.7
|
13
|
33.3
| |
|
40–49
|
62
|
49.2
|
64
|
50.8
| |
34
|
50.0
|
34
|
50.0
| |
28
|
48.3
|
30
|
51.7
| |
|
50–59
|
97
|
56.7
|
74
|
43.3
| |
42
|
51.2
|
40
|
48.8
| |
55
|
61.8
|
34
|
38.2
| |
|
> =60
|
31
|
41.3
|
44
|
58.7
| |
15
|
36.6
|
26
|
63.4
| |
16
|
47.1
|
18
|
52.9
| |
|
Race
|
0.055
| | | | |
0.558
| | | | |
0.040
|
|
White
|
216
|
51.9
|
200
|
48.1
| |
104
|
49.1
|
108
|
50.9
| |
112
|
54.9
|
92
|
45.1
| |
|
Nonwhite
|
21
|
70.0
|
9
|
30.0
| |
8
|
57.1
|
6
|
42.9
| |
13
|
81.3
|
< 53
|
–
| |
|
Ethnicity
|
0.020
| | | | |
0.439
| | | | |
0.011
|
|
Hispanic
|
45
|
66.2
|
23
|
33.8
| |
19
|
55.9
|
15
|
44.1
| |
26
|
76.5
|
8
|
23.5
| |
|
Non-Hispanic
|
189
|
50.8
|
183
|
49.2
| |
92
|
48.7
|
97
|
51.3
| |
97
|
53.0
|
86
|
47.0
| |
|
Geography
|
0.909
| | | | |
0.904
| | | | |
0.874
|
|
Rural
|
32
|
52.5
|
29
|
47.5
| |
18
|
48.7
|
19
|
51.4
| |
14
|
58.3
|
10
|
41.7
| |
|
Metro-politan
|
205
|
53.3
|
180
|
46.8
| |
94
|
49.7
|
95
|
50.3
| |
111
|
56.6
|
85
|
43.4
| |
|
Cancer site
|
0.144
| | | | |
0.074
| | | | |
0.728
|
|
Colorectal
|
77
|
60.2
|
51
|
39.8
| |
37
|
58.7
|
26
|
41.3
| |
40
|
61.5
|
25
|
38.5
| |
|
Myeloma
|
31
|
48.4
|
33
|
51.6
| |
12
|
37.5
|
20
|
62.5
| |
19
|
59.4
|
13
|
40.6
| |
|
Breast
|
51
|
52.6
|
46
|
47.4
| |
24
|
47.1
|
27
|
52.9
| |
27
|
58.7
|
19
|
41.3
| |
|
Ovarian
|
26
|
41.3
|
37
|
58.7
| |
11
|
34.4
|
21
|
65.6
| |
15
|
48.4
|
16
|
51.6
| |
|
Prostate
|
52
|
55.3
|
42
|
44.7
| |
28
|
58.3
|
20
|
41.7
| |
24
|
52.2
|
22
|
47.8
| |
|
Stage
|
0.174
| | | | |
0.162
| | | | |
0.652
|
|
In situ
|
10
|
41.7
|
14
|
58.3
| |
< 53
|
–
|
7
|
70.0
| |
7
|
50.0
|
7
|
50.0
| |
|
Localized
|
118
|
55.9
|
93
|
44.1
| |
57
|
51.4
|
54
|
48.7
| |
61
|
61.0
|
39
|
39.0
| |
|
Regional
|
65
|
57.0
|
49
|
43.0
| |
32
|
58.2
|
23
|
41.8
| |
33
|
55.9
|
26
|
44.1
| |
|
Distant
|
44
|
45.4
|
53
|
54.6
| |
20
|
40.0
|
30
|
60.0
| |
24
|
51.1
|
23
|
48.9
| |
- 1. Percent of respondents equates to response rate
- 2. P-values for statistically significant comparisons are presented in boldface.
- 3. Cell counts less than five are masked for protection of confidentiality
